Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differing activities of quinolones against ciprofloxacin-susceptible and ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus.

Antimicrobial agents and chemotherapy - 1 Feb 1991

Maple P A, Hamilton-Miller J M, Brumfitt W

Abstract excerpt

The in vitro activities of nine quinolones (seven fluoroquinolones, nalidixic acid, and acrosoxacin) against methicillin-resistant Staphylococcus aureus (MRSA) were compared with those of the glycopeptides teicoplanin and vancomycin. MICs against 160 strains of ciprofloxacin-susceptible (MIC, less than 2.0 micrograms/ml) MRSA and 40 strains of ciprofloxacin-resistant (MIC, greater than or equal to 2.0...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to Anti-Infective Agents

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Resistance, Microbial

Share to Methicillin Resistance

Share to Microbial Sensitivity Tests

Share to Mutation

Share to Staphylococcal Infections

Share to Staphylococcus aureus

Source

Open in PubMed Open full text

Identifiers

PMID: 1827242
DOI: 10.1128/AAC.35.2.345
PMCID: PMC245003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differing activities of quinolones against ciprofloxacin-susceptible and ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus.PMID 1827242Read ↗

The effects of increasing levels of quinolone resistance on in-vitro activity of four quinolones.Semantic proximity Read ↗

Quinolone resistance in Staphylococci: activities of new nonfluorinated quinolones against molecular targets in whole cells and clinical isolates.Semantic proximity Read ↗

In vitro activities of six quinolones and mechanisms of resistance in Staphylococcus aureus and coagulase-negative staphylococci.Semantic proximity Read ↗

In vitro studies with five quinolones: evidence for changes in relative potency as quinolone resistance rises.Semantic proximity Read ↗

In vitro activity of AT-4140 against quinolone- and methicillin-resistant Staphylococcus aureus.Semantic proximity Read ↗

Molecular epidemiology of quinolone resistance and comparative in vitro activities of new quinolones against European Staphylococcus aureus isolates.Semantic proximity Read ↗

Mechanism of quinolone resistance in Staphylococcus aureus.Semantic proximity Read ↗

Mutation rates to 4-quinolone resistance.Semantic proximity Read ↗

Spontaneously occurring staphylococcal mutants resistant to clinically achievable concentrations of ciprofloxacin and temafloxacin.Semantic proximity Read ↗

Correlation between the activity of different fluoroquinolones and the presence of mechanisms of quinolone resistance in epidemiologically related and unrelated strains of methicillin-susceptible and -resistant Staphylococcus aureus.Semantic proximity Read ↗

Activity of moxifloxacin against pathogens with decreased susceptibility to ciprofloxacin.Semantic proximity Read ↗

Activity of BMS-284756, a novel des-fluoro(6) quinolone, against Staphylococcus aureus, including contributions of mutations to quinolone resistance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.